Search research articles
Contact Us
Filters
Showing results (41-50 of 145) with videos related to
Page
of 15
Sort By:
International Journal of Clinical Pharmacy
|
June 3, 2017
Using pharmacy management systems for research: survival outcomes for lenalidomide in multiple myeloma in the clinical setting
Megan M Sharkey, Daniel McKavanagh, Euan Walpole, et al.
Leukemia & Lymphoma
|
December 8, 2010
Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: results from an Australian population
Kirk Morris, Helen Weston, Peter Mollee, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
February 23, 2013
Using HitAlert flow cytometry to detect heparin-induced thrombocytopenia antibodies in a tertiary care hospital
Connie Solano, Howard Mutsando, Marlene Self, et al.
Clinical Chemistry and Laboratory Medicine
|
December 20, 2015
Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis
Alice Kennard, Carmel Hawley, Jill Tate, et al.
The Medical Journal of Australia
|
August 11, 2018
Relative survival of patients with lymphoma in Queensland according to histological subtype
Fraser Wright, Greg Hapgood, Aravi Loganathan, et al.
Leukemia & Lymphoma
|
June 16, 2020
Identifying an obinutuzumab resistant subpopulation of monocyte-derived-macrophages from patients with CLL
Melinda Burgess, Yu Chen Enya Chen, Sally Mapp, et al.
Heart, Lung & Circulation
|
March 4, 2017
The Utility of <sup>99m</sup>Tc-DPD Scintigraphy in the Diagnosis of Cardiac Amyloidosis: An Australian Experience
Peter T Moore, Matthew K Burrage, Emily Mackenzie, et al.
Leukemia & Lymphoma
|
April 20, 2013
Outcomes and prognostic factors for patients with acute myeloid leukemia admitted to the intensive care unit
Kathryn Jackson, Peter Mollee, Kirk Morris, et al.
Hematology (Amsterdam, Netherlands)
|
March 9, 2006
A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma
John Kuruvilla, Kevin Song, Peter Mollee, et al.
Leukemia & Lymphoma
|
June 26, 2019
High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy
Courtney Tate, Melinda Burgess, Nigel A McMillan, et al.
Page
of 15
Search research articles
Search
Showing results (41-50 of 145) with videos related to
Sort By:
Page
of 15
International Journal of Clinical Pharmacy
|
June 3, 2017
Using pharmacy management systems for research: survival outcomes for lenalidomide in multiple myeloma in the clinical setting
Megan M Sharkey, Daniel McKavanagh, Euan Walpole, et al.
Leukemia & Lymphoma
|
December 8, 2010
Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: results from an Australian population
Kirk Morris, Helen Weston, Peter Mollee, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
February 23, 2013
Using HitAlert flow cytometry to detect heparin-induced thrombocytopenia antibodies in a tertiary care hospital
Connie Solano, Howard Mutsando, Marlene Self, et al.
Clinical Chemistry and Laboratory Medicine
|
December 20, 2015
Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis
Alice Kennard, Carmel Hawley, Jill Tate, et al.
The Medical Journal of Australia
|
August 11, 2018
Relative survival of patients with lymphoma in Queensland according to histological subtype
Fraser Wright, Greg Hapgood, Aravi Loganathan, et al.
Leukemia & Lymphoma
|
June 16, 2020
Identifying an obinutuzumab resistant subpopulation of monocyte-derived-macrophages from patients with CLL
Melinda Burgess, Yu Chen Enya Chen, Sally Mapp, et al.
Heart, Lung & Circulation
|
March 4, 2017
The Utility of <sup>99m</sup>Tc-DPD Scintigraphy in the Diagnosis of Cardiac Amyloidosis: An Australian Experience
Peter T Moore, Matthew K Burrage, Emily Mackenzie, et al.
Leukemia & Lymphoma
|
April 20, 2013
Outcomes and prognostic factors for patients with acute myeloid leukemia admitted to the intensive care unit
Kathryn Jackson, Peter Mollee, Kirk Morris, et al.
Hematology (Amsterdam, Netherlands)
|
March 9, 2006
A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma
John Kuruvilla, Kevin Song, Peter Mollee, et al.
Leukemia & Lymphoma
|
June 26, 2019
High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy
Courtney Tate, Melinda Burgess, Nigel A McMillan, et al.
Page
of 15